Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04884594
PHASE1

AAV8-hCocH for Cocaine Use Disorder

Sponsor: W. Michael Hooten

View on ClinicalTrials.gov

Summary

The purpose of this study is to test the safety of a novel gene viral vector treatment for adults with cocaine use disorder-sustained remission. This gene regulates an enzyme (cocaine hydrolase) that breaks down cocaine into inactive substances, thereby decreasing the pleasurable feeling this drug usually provides.

Official title: Intravenous Administration of AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2021-10-08

Completion Date

2026-12

Last Updated

2026-03-27

Healthy Volunteers

Yes

Interventions

DRUG

AAV8-hCocH

2e12 vg/kg single infusion intravenous

DRUG

AAV8-hCocH

6e12 vg/kg single infusion intravenous

DRUG

AAV8-hCocH

4e12 vg/kg single infusion intravenous

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States